Vaccine Stamaril Pasteur (0.5 ml) (Yellow Fever Vaccine)

Stamaril is a live attenuated vaccine designed to protect against yellow fever, a dangerous viral disease transmitted through bites of infected mosquitoes. The disease is prevalent in certain African and South American countries. The vaccine is manufactured by Sanofi Pasteur, and it contains the attenuated yellow fever virus (17D strain), which elicits a long-term immune response.

Key Information:

• Indications: The vaccine is intended for individuals from 9 months of age traveling to or living in endemic areas, as well as those required by international travel regulations (IHR).

• Administration: A single subcutaneous or intramuscular injection (0.5 ml).

• Onset of Protection: Immunity develops within 10 days after vaccination.

• Duration of Protection: One dose is sufficient for a lifetime (according to WHO recommendations).

• Vaccination Certificate: Issued and takes effect 10 days after the shot; required for entry into certain countries (International Certificate of Vaccination or Prophylaxis – ICVP).

• Contraindications: Severe allergy to egg proteins, immunosuppression, pregnancy (relative contraindication), infants under 9 months (except in outbreak situations), certain chronic diseases.

Important:
The Stamaril vaccine can only be administered at certified yellow fever vaccination centers, and a vaccination certificate is required in many countries as a mandatory international travel requirement.